-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QKVQtqWZxIGtIGHTltonsLmCqqJeh3HSdCilR2tQDC+BGnd1FgRHafxhCOKkw9mt jFjlYkBaoE01W4TxiO3+2g== 0001104659-03-014347.txt : 20030709 0001104659-03-014347.hdr.sgml : 20030709 20030709172545 ACCESSION NUMBER: 0001104659-03-014347 CONFORMED SUBMISSION TYPE: 11-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021231 FILED AS OF DATE: 20030709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ANIKA THERAPEUTICS INC CENTRAL INDEX KEY: 0000898437 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043145961 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 11-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14027 FILM NUMBER: 03780714 BUSINESS ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 6179326616 MAIL ADDRESS: STREET 1: 236 WEST CUMMINGS PARK CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: ANIKA RESEARCH INC DATE OF NAME CHANGE: 19930309 11-K 1 j2337_11k.htm 11-K

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 11-K

 

ANNUAL REPORT

PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

(Mark One:)

ý

ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

 

 

For the fiscal year ended December 31, 2002

 

 

OR

 

 

o

TRANSITION REPORT PURSUANT TO SECTION 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

 

For the transition period from                       to                      

 

Commission file number: 000-21326

 

A.  Full title of the plan and the address of the plan, if different from that of the issuer named below:

 

Anika Therapeutics, Inc.

401(K) Plan

 

B.  Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

 

Anika Therapeutics, Inc.

160 New Boston Street

Woburn, MA 01801

(781) 932-6616

 

 



 

REQUIRED INFORMATION

 

Item 4.  Plan financial statements and schedule for the year ended December 31, 2002 have been prepared in accordance with the financial reporting requirements of ERISA.

 

Statements of Net Assets Available for Benefits as of December 31, 2002  and 2001

 

Statement of Changes in Net Assets Available for Benefits for the year ended December 31, 2002

 

 

Signature

 

The Plan.  Pursuant to the requirements of the Securities Exchange Act of 1934, the trustees have duly caused this annual report to be signed on their behalf by the undersigned hereunto duly authorized.

 

 

 

Anika Therapeutics, Inc.

 

Employee Savings and Retirement Plan

 

 

 

 

By: /s/ William J. Knight

 

 

 

William J. Knight, Trustee

 

 

 

 

 

 

 

Dated:  June 27, 2003

 

 

2



 

ANIKA THERAPEUTICS, INC.
EMPLOYEE SAVINGS & RETIREMENT PLAN

 

STATEMENTS OF NET ASSETS AVAILABLE FOR BENEFITS
AS OF DECEMBER 31, 2002 and 2001

 

 

 

2002

 

2001

 

INVESTMENTS

 

 

 

 

 

Participant directed, at fair value -

 

 

 

 

 

Money market fund

 

$

411,032

 

$

297,788

 

Employer common stock

 

79,276

 

68,422

 

Mutual funds

 

1,073,958

 

1,229,504

 

Participant loans

 

32,265

 

84,839

 

Total investments

 

1,596,531

 

1,680,553

 

 

 

 

 

 

 

CONTRIBUTIONS RECEIVABLE

 

12,389

 

22,396

 

 

 

 

 

 

 

NET ASSETS AVAILABLE FOR BENEFITS

 

$

1,608,920

 

$

1,702,949

 

 

F-1



 

Anika Therapeutics, Inc.
Employee Savings & Retirement Plan

 

STATEMENT OF CHANGES IN NET ASSETS AVAILABLE FOR BENEFITS
FOR THE YEAR ENDED DECEMBER 31, 2002

 

 

 

2002

 

 

 

 

 

Interest & dividends

 

$

25,020

 

 

 

 

 

Contributions by:

 

 

 

Employees

 

246,423

 

Employer

 

150,109

 

Rollover distributions, net

 

(17,151

)

Total contributions

 

379,381

 

 

 

 

 

Total additions

 

404,401

 

 

 

 

 

Less:

 

 

 

Distributions to former participants

 

210,941

 

Net increase (decrease) before realized gains(losses)

 

193,460

 

 

 

 

 

Net realized and unrealized investment gains(losses)

 

(287,489

)

Net decrease in net assets

 

(94,029

)

Net assets available for benefits, beginning of year

 

1,702,949

 

Net assets available for benefits, end of year

 

$

1,608,920

 

 

F-2


-----END PRIVACY-ENHANCED MESSAGE-----